Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Beyond Air Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
XAIR
Nasdaq
3841
http://www.ait-pharm.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Beyond Air Inc
Beyond Air® Presents Positive Study Update from the At-Home LungFit® GO Pilot Study for Nontuberculous Mycobacterial Lung Disease at the American Thoracic Society International Conference 2022
- May 17th, 2022 8:05 pm
Beyond Cancer, Ltd. Appoints Susan Howell Jones, CPA as Chief Financial Officer
- May 17th, 2022 11:00 am
Beyond Air® Schedules Fiscal Year 2022 Financial Results Conference Call and Webcast
- May 16th, 2022 11:05 am
Loss-Making Beyond Air, Inc. (NASDAQ:XAIR) Expected To Breakeven In The Medium-Term
- May 6th, 2022 10:29 am
Beyond Air® Reports Positive Long-Term Safety Data for High Concentration Inhaled Nitric Oxide in Bronchiolitis at the Pediatric Academic Societies Meeting 2022
- Apr 25th, 2022 8:05 pm
Beyond Air® Presents Positive Safety and Efficacy Data for Inhaled Nitric Oxide to Treat COVID-19 at ECCMID 2022
- Apr 25th, 2022 11:00 am
Beyond Air® to Participate in Three Upcoming Medical Conferences
- Apr 18th, 2022 11:00 am
Beyond Cancer™ Announces New Preclinical Data Presented at American Association for Cancer Research (AACR) Showing Ultra-High Concentration Nitric Oxide Therapy Anti-Tumor Effect
- Apr 11th, 2022 11:00 am
Beyond Cancer™ to Present Two Abstracts for Ultra-High Concentration Nitric Oxide Therapy at the 2022 AACR Annual Meeting
- Mar 8th, 2022 9:35 pm
Beyond Air (NASDAQ:XAIR) Is In A Good Position To Deliver On Growth Plans
- Feb 22nd, 2022 9:52 am
Beyond Air® Reports Financial Results for the Third Quarter of Fiscal Year 2022
- Feb 10th, 2022 9:05 pm
Beyond Air® Announces Participation at Upcoming Investor Conferences in March 2022
- Feb 8th, 2022 1:00 pm
Beyond Air® Announces Two Appointments to Beyond Cancer™ Board of Directors
- Feb 3rd, 2022 9:05 pm
Beyond Air® Schedules Third Fiscal Quarter 2022 Financial Results Conference Call and Webcast
- Jan 27th, 2022 1:00 pm
Beyond Air Inc (XAIR) CEO and Chairman of the Board Steven A. Lisi Bought $341,200 of Shares
- Dec 14th, 2021 2:15 pm
Implied Volatility Surging for Beyond Air (XAIR) Stock Options
- Dec 10th, 2021 2:14 pm
Beyond Air® Provides Regulatory Update for LungFit® PH
- Dec 9th, 2021 1:30 pm
Beyond Air Slides After LungFit Launch Delay
- Dec 9th, 2021 10:56 am
Beyond Air® Expands Leadership Team with the Appointment of Dr. Andrew Colin to Chief Medical Officer
- Dec 1st, 2021 1:00 pm
Beyond Air® Announces $30 Million of Committed Capital in Previously Reported Beyond Cancer™ Private Placement
- Nov 18th, 2021 9:05 pm
Scroll